They found that PES1 enhances the stability of ERα while simultaneously targeting ERβ for proteasome degradation, thereby increasing the protein level of ERα and decreasing that of ERβ, which contributes to the occurrence and development of breast cancer and ovarian cancer. Here, ESR1 is linked to ovarian carcinoma.